nodes	percent_of_prediction	percent_of_DWPC	metapath
Carboprost Tromethamine—PTGFR—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.0297	0.192	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.029	0.188	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—respiratory system—chronic obstructive pulmonary disease	0.01	0.257	CbGeAlD
Carboprost Tromethamine—PTGFR—bronchus—chronic obstructive pulmonary disease	0.00823	0.211	CbGeAlD
Carboprost Tromethamine—PTGFR—smooth muscle tissue—chronic obstructive pulmonary disease	0.00805	0.207	CbGeAlD
Carboprost Tromethamine—PTGFR—trachea—chronic obstructive pulmonary disease	0.00739	0.19	CbGeAlD
Carboprost Tromethamine—PTGFR—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.00724	0.0469	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.00708	0.0459	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Other—CXCR2—chronic obstructive pulmonary disease	0.00531	0.0345	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—lung—chronic obstructive pulmonary disease	0.00531	0.136	CbGeAlD
Carboprost Tromethamine—Sleep disorder—Formoterol—chronic obstructive pulmonary disease	0.00497	0.00616	CcSEcCtD
Carboprost Tromethamine—Sleep disorder—Arformoterol—chronic obstructive pulmonary disease	0.00497	0.00616	CcSEcCtD
Carboprost Tromethamine—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.00496	0.00614	CcSEcCtD
Carboprost Tromethamine—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.00494	0.00612	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.00491	0.00608	CcSEcCtD
Carboprost Tromethamine—Sleep disorder—Montelukast—chronic obstructive pulmonary disease	0.00487	0.00603	CcSEcCtD
Carboprost Tromethamine—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00466	0.00578	CcSEcCtD
Carboprost Tromethamine—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00458	0.00568	CcSEcCtD
Carboprost Tromethamine—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.00451	0.00559	CcSEcCtD
Carboprost Tromethamine—Thirst—Montelukast—chronic obstructive pulmonary disease	0.00443	0.00549	CcSEcCtD
Carboprost Tromethamine—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.00434	0.00538	CcSEcCtD
Carboprost Tromethamine—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.00433	0.00537	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Tiotropium—chronic obstructive pulmonary disease	0.00428	0.0053	CcSEcCtD
Carboprost Tromethamine—Infection—Roflumilast—chronic obstructive pulmonary disease	0.00414	0.00513	CcSEcCtD
Carboprost Tromethamine—Urinary tract infection—Tiotropium—chronic obstructive pulmonary disease	0.00399	0.00495	CcSEcCtD
Carboprost Tromethamine—Epistaxis—Tiotropium—chronic obstructive pulmonary disease	0.00387	0.0048	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00379	0.0047	CcSEcCtD
Carboprost Tromethamine—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.00372	0.00461	CcSEcCtD
Carboprost Tromethamine—Asthma—Formoterol—chronic obstructive pulmonary disease	0.00372	0.00461	CcSEcCtD
Carboprost Tromethamine—Abdominal pain upper—Salbutamol—chronic obstructive pulmonary disease	0.00371	0.0046	CcSEcCtD
Carboprost Tromethamine—Asthma—Montelukast—chronic obstructive pulmonary disease	0.00364	0.00451	CcSEcCtD
Carboprost Tromethamine—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00363	0.0045	CcSEcCtD
Carboprost Tromethamine—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.00351	0.00435	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Arformoterol—chronic obstructive pulmonary disease	0.00345	0.00428	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Formoterol—chronic obstructive pulmonary disease	0.00345	0.00428	CcSEcCtD
Carboprost Tromethamine—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.00342	0.00424	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Montelukast—chronic obstructive pulmonary disease	0.00338	0.00419	CcSEcCtD
Carboprost Tromethamine—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00334	0.00414	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCRs, Other—ADRB2—chronic obstructive pulmonary disease	0.00333	0.0216	CbGpPWpGaD
Carboprost Tromethamine—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.0033	0.0041	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.00326	0.00404	CcSEcCtD
Carboprost Tromethamine—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00325	0.00402	CcSEcCtD
Carboprost Tromethamine—Urinary tract infection—Formoterol—chronic obstructive pulmonary disease	0.00322	0.00399	CcSEcCtD
Carboprost Tromethamine—Urinary tract infection—Arformoterol—chronic obstructive pulmonary disease	0.00322	0.00399	CcSEcCtD
Carboprost Tromethamine—Hiccups—Prednisolone—chronic obstructive pulmonary disease	0.00321	0.00398	CcSEcCtD
Carboprost Tromethamine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00313	0.00388	CcSEcCtD
Carboprost Tromethamine—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.0031	0.00385	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00307	0.0038	CcSEcCtD
Carboprost Tromethamine—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.00306	0.00379	CcSEcCtD
Carboprost Tromethamine—Urinary tract infection—Salbutamol—chronic obstructive pulmonary disease	0.00304	0.00377	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00302	0.00375	CcSEcCtD
Carboprost Tromethamine—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.00301	0.00373	CcSEcCtD
Carboprost Tromethamine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00299	0.0037	CcSEcCtD
Carboprost Tromethamine—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.00295	0.00366	CcSEcCtD
Carboprost Tromethamine—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00293	0.00363	CcSEcCtD
Carboprost Tromethamine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00289	0.00358	CcSEcCtD
Carboprost Tromethamine—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00288	0.00357	CcSEcCtD
Carboprost Tromethamine—Pulmonary oedema—Prednisolone—chronic obstructive pulmonary disease	0.00286	0.00354	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00285	0.00353	CcSEcCtD
Carboprost Tromethamine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00284	0.00351	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00282	0.0035	CcSEcCtD
Carboprost Tromethamine—Cough—Tiotropium—chronic obstructive pulmonary disease	0.0028	0.00347	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00278	0.00344	CcSEcCtD
Carboprost Tromethamine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00277	0.00343	CcSEcCtD
Carboprost Tromethamine—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00276	0.00342	CcSEcCtD
Carboprost Tromethamine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00275	0.00341	CcSEcCtD
Carboprost Tromethamine—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00273	0.00339	CcSEcCtD
Carboprost Tromethamine—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00273	0.00339	CcSEcCtD
Carboprost Tromethamine—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00273	0.00339	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00271	0.00336	CcSEcCtD
Carboprost Tromethamine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00265	0.00328	CcSEcCtD
Carboprost Tromethamine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00263	0.00325	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00262	0.00325	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.00262	0.00325	CcSEcCtD
Carboprost Tromethamine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00261	0.00323	CcSEcCtD
Carboprost Tromethamine—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00261	0.00323	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCRs, Other—HTR2A—chronic obstructive pulmonary disease	0.00261	0.0169	CbGpPWpGaD
Carboprost Tromethamine—Infection—Tiotropium—chronic obstructive pulmonary disease	0.0026	0.00322	CcSEcCtD
Carboprost Tromethamine—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00258	0.00319	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00256	0.00317	CcSEcCtD
Carboprost Tromethamine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00254	0.00315	CcSEcCtD
Carboprost Tromethamine—Tension—Formoterol—chronic obstructive pulmonary disease	0.00254	0.00315	CcSEcCtD
Carboprost Tromethamine—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00252	0.00312	CcSEcCtD
Carboprost Tromethamine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.00252	0.00312	CcSEcCtD
Carboprost Tromethamine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.00252	0.00312	CcSEcCtD
Carboprost Tromethamine—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.0025	0.0031	CcSEcCtD
Carboprost Tromethamine—Back pain—Formoterol—chronic obstructive pulmonary disease	0.0025	0.0031	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00249	0.00309	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00249	0.00309	CcSEcCtD
Carboprost Tromethamine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00247	0.00307	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00244	0.00302	CcSEcCtD
Carboprost Tromethamine—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.00241	0.00298	CcSEcCtD
Carboprost Tromethamine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.0024	0.00297	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00239	0.00296	CcSEcCtD
Carboprost Tromethamine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00237	0.00294	CcSEcCtD
Carboprost Tromethamine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00237	0.00293	CcSEcCtD
Carboprost Tromethamine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00237	0.00293	CcSEcCtD
Carboprost Tromethamine—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00237	0.00293	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00235	0.00291	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00235	0.00291	CcSEcCtD
Carboprost Tromethamine—Hiccups—Prednisone—chronic obstructive pulmonary disease	0.00233	0.00289	CcSEcCtD
Carboprost Tromethamine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00232	0.00287	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.00231	0.015	CbGpPWpGaD
Carboprost Tromethamine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00229	0.00284	CcSEcCtD
Carboprost Tromethamine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00229	0.00284	CcSEcCtD
Carboprost Tromethamine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00226	0.0028	CcSEcCtD
Carboprost Tromethamine—Cough—Formoterol—chronic obstructive pulmonary disease	0.00226	0.0028	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.00226	0.0147	CbGpPWpGaD
Carboprost Tromethamine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00224	0.00278	CcSEcCtD
Carboprost Tromethamine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00224	0.00277	CcSEcCtD
Carboprost Tromethamine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00224	0.00277	CcSEcCtD
Carboprost Tromethamine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00223	0.00277	CcSEcCtD
Carboprost Tromethamine—Cough—Montelukast—chronic obstructive pulmonary disease	0.00221	0.00274	CcSEcCtD
Carboprost Tromethamine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.0022	0.00273	CcSEcCtD
Carboprost Tromethamine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.0022	0.00273	CcSEcCtD
Carboprost Tromethamine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.0022	0.00273	CcSEcCtD
Carboprost Tromethamine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.0022	0.00273	CcSEcCtD
Carboprost Tromethamine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.0022	0.00272	CcSEcCtD
Carboprost Tromethamine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.0022	0.00272	CcSEcCtD
Carboprost Tromethamine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.0022	0.00272	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.0022	0.00272	CcSEcCtD
Carboprost Tromethamine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00219	0.00272	CcSEcCtD
Carboprost Tromethamine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00216	0.00268	CcSEcCtD
Carboprost Tromethamine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00216	0.00268	CcSEcCtD
Carboprost Tromethamine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00215	0.00267	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00215	0.00266	CcSEcCtD
Carboprost Tromethamine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00213	0.00264	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00211	0.00262	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00211	0.00262	CcSEcCtD
Carboprost Tromethamine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00211	0.00262	CcSEcCtD
Carboprost Tromethamine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.0021	0.0026	CcSEcCtD
Carboprost Tromethamine—Infection—Formoterol—chronic obstructive pulmonary disease	0.0021	0.0026	CcSEcCtD
Carboprost Tromethamine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00208	0.00258	CcSEcCtD
Carboprost Tromethamine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00208	0.00258	CcSEcCtD
Carboprost Tromethamine—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.00208	0.00257	CcSEcCtD
Carboprost Tromethamine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00207	0.00257	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00207	0.00257	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00206	0.00256	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00206	0.00256	CcSEcCtD
Carboprost Tromethamine—Infection—Montelukast—chronic obstructive pulmonary disease	0.00206	0.00255	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00205	0.00254	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.002	0.00247	CcSEcCtD
Carboprost Tromethamine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00198	0.00246	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00198	0.0128	CbGpPWpGaD
Carboprost Tromethamine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00196	0.00243	CcSEcCtD
Carboprost Tromethamine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00196	0.00243	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00195	0.00241	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00194	0.0126	CbGpPWpGaD
Carboprost Tromethamine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00193	0.00239	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00193	0.00239	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00193	0.00239	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00193	0.00239	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.0019	0.00235	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00189	0.00234	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00188	0.00234	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00188	0.00234	CcSEcCtD
Carboprost Tromethamine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00188	0.00233	CcSEcCtD
Carboprost Tromethamine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00188	0.00233	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00186	0.0023	CcSEcCtD
Carboprost Tromethamine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00184	0.00228	CcSEcCtD
Carboprost Tromethamine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00184	0.00228	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00182	0.00225	CcSEcCtD
Carboprost Tromethamine—Pain—Formoterol—chronic obstructive pulmonary disease	0.00181	0.00224	CcSEcCtD
Carboprost Tromethamine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00181	0.00224	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00179	0.00222	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00178	0.00221	CcSEcCtD
Carboprost Tromethamine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00177	0.0022	CcSEcCtD
Carboprost Tromethamine—Pain—Montelukast—chronic obstructive pulmonary disease	0.00177	0.00219	CcSEcCtD
Carboprost Tromethamine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00177	0.00219	CcSEcCtD
Carboprost Tromethamine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00175	0.00217	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00175	0.00217	CcSEcCtD
Carboprost Tromethamine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00174	0.00216	CcSEcCtD
Carboprost Tromethamine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00173	0.00215	CcSEcCtD
Carboprost Tromethamine—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.00173	0.00214	CcSEcCtD
Carboprost Tromethamine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00171	0.00212	CcSEcCtD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.00167	0.0109	CbGpPWpGaD
Carboprost Tromethamine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00167	0.00207	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00167	0.00207	CcSEcCtD
Carboprost Tromethamine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00167	0.00206	CcSEcCtD
Carboprost Tromethamine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00165	0.00205	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00165	0.00204	CcSEcCtD
Carboprost Tromethamine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00165	0.00204	CcSEcCtD
Carboprost Tromethamine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00164	0.00203	CcSEcCtD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.00164	0.0106	CbGpPWpGaD
Carboprost Tromethamine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00164	0.00203	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00158	0.00196	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00156	0.00193	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00156	0.00193	CcSEcCtD
Carboprost Tromethamine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00156	0.00193	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00153	0.00189	CcSEcCtD
Carboprost Tromethamine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00152	0.00188	CcSEcCtD
Carboprost Tromethamine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00152	0.00188	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.00151	0.00977	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.0015	0.00971	CbGpPWpGaD
Carboprost Tromethamine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00149	0.00184	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.00147	0.00956	CbGpPWpGaD
Carboprost Tromethamine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00147	0.00182	CcSEcCtD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.00147	0.00951	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.00146	0.0095	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.00145	0.00939	CbGpPWpGaD
Carboprost Tromethamine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00145	0.00179	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00145	0.00179	CcSEcCtD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.00143	0.0093	CbGpPWpGaD
Carboprost Tromethamine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00143	0.00177	CcSEcCtD
Carboprost Tromethamine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.00142	0.00177	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.00142	0.00919	CbGpPWpGaD
Carboprost Tromethamine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00142	0.00176	CcSEcCtD
Carboprost Tromethamine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.0014	0.00173	CcSEcCtD
Carboprost Tromethamine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.0014	0.00173	CcSEcCtD
Carboprost Tromethamine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00137	0.0017	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00137	0.00169	CcSEcCtD
Carboprost Tromethamine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00134	0.00167	CcSEcCtD
Carboprost Tromethamine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00134	0.00167	CcSEcCtD
Carboprost Tromethamine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00133	0.00165	CcSEcCtD
Carboprost Tromethamine—Rash—Formoterol—chronic obstructive pulmonary disease	0.00133	0.00165	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00133	0.00165	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00133	0.00165	CcSEcCtD
Carboprost Tromethamine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00132	0.00164	CcSEcCtD
Carboprost Tromethamine—Headache—Formoterol—chronic obstructive pulmonary disease	0.00132	0.00164	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00132	0.00164	CcSEcCtD
Carboprost Tromethamine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00132	0.00164	CcSEcCtD
Carboprost Tromethamine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00132	0.00163	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.00131	0.0085	CbGpPWpGaD
Carboprost Tromethamine—Rash—Montelukast—chronic obstructive pulmonary disease	0.00131	0.00162	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.0013	0.00162	CcSEcCtD
Carboprost Tromethamine—Headache—Montelukast—chronic obstructive pulmonary disease	0.0013	0.00161	CcSEcCtD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.00128	0.00832	CbGpPWpGaD
Carboprost Tromethamine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00128	0.00159	CcSEcCtD
Carboprost Tromethamine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00157	CcSEcCtD
Carboprost Tromethamine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00126	0.00156	CcSEcCtD
Carboprost Tromethamine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00126	0.00156	CcSEcCtD
Carboprost Tromethamine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00126	0.00156	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00126	0.00156	CcSEcCtD
Carboprost Tromethamine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00126	0.00156	CcSEcCtD
Carboprost Tromethamine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00126	0.00156	CcSEcCtD
Carboprost Tromethamine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.00155	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00124	0.00805	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00123	0.008	CbGpPWpGaD
Carboprost Tromethamine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00123	0.00153	CcSEcCtD
Carboprost Tromethamine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00123	0.00152	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00121	0.00788	CbGpPWpGaD
Carboprost Tromethamine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00121	0.0015	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00121	0.00783	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.00147	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00114	0.00142	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.00113	0.00734	CbGpPWpGaD
Carboprost Tromethamine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.00113	0.0014	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00112	0.00138	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.00111	0.00719	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.00111	0.00719	CbGpPWpGaD
Carboprost Tromethamine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00111	0.00137	CcSEcCtD
Carboprost Tromethamine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.00109	0.00135	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.00109	0.00704	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.00106	0.00685	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.00103	0.0067	CbGpPWpGaD
Carboprost Tromethamine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00103	0.00127	CcSEcCtD
Carboprost Tromethamine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000979	0.00121	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.00097	0.00629	CbGpPWpGaD
Carboprost Tromethamine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00096	0.00119	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000959	0.00622	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000949	0.00616	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000945	0.00613	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000938	0.00609	CbGpPWpGaD
Carboprost Tromethamine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000931	0.00115	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000925	0.006	CbGpPWpGaD
Carboprost Tromethamine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000916	0.00113	CcSEcCtD
Carboprost Tromethamine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000914	0.00113	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000896	0.00111	CcSEcCtD
Carboprost Tromethamine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.00088	0.00109	CcSEcCtD
Carboprost Tromethamine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000868	0.00108	CcSEcCtD
Carboprost Tromethamine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000865	0.00107	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000851	0.00552	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000844	0.00548	CbGpPWpGaD
Carboprost Tromethamine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000843	0.00105	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000833	0.0054	CbGpPWpGaD
Carboprost Tromethamine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000832	0.00103	CcSEcCtD
Carboprost Tromethamine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000826	0.00102	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000826	0.00536	CbGpPWpGaD
Carboprost Tromethamine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000818	0.00101	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000812	0.00101	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000804	0.000997	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000773	0.00501	CbGpPWpGaD
Carboprost Tromethamine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000758	0.000939	CcSEcCtD
Carboprost Tromethamine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000757	0.000938	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000756	0.00491	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000747	0.00485	CbGpPWpGaD
Carboprost Tromethamine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000747	0.000926	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000738	0.00479	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000731	0.00474	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000723	0.00469	CbGpPWpGaD
Carboprost Tromethamine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000722	0.000894	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000721	0.000894	CcSEcCtD
Carboprost Tromethamine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000717	0.000889	CcSEcCtD
Carboprost Tromethamine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00068	0.000843	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000658	0.000815	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000613	0.000759	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000599	0.00389	CbGpPWpGaD
Carboprost Tromethamine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000597	0.00074	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.000591	0.00384	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000586	0.0038	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.000579	0.00375	CbGpPWpGaD
Carboprost Tromethamine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000569	0.000705	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000566	0.00367	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000554	0.0036	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00055	0.000682	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000534	0.00346	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000529	0.000655	CcSEcCtD
Carboprost Tromethamine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000524	0.00065	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000524	0.000649	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000523	0.00339	CbGpPWpGaD
Carboprost Tromethamine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000521	0.000646	CcSEcCtD
Carboprost Tromethamine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000494	0.000612	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000485	0.00314	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000477	0.00309	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000474	0.00308	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000467	0.00303	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000456	0.00296	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000456	0.00296	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.000454	0.00295	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000447	0.0029	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000447	0.0029	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.000445	0.00289	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000433	0.00281	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000424	0.00275	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000417	0.00271	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000408	0.00265	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000379	0.00246	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000371	0.00241	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000334	0.00217	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000327	0.00212	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.00031	0.00201	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000304	0.00197	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000286	0.00186	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.00028	0.00182	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000258	0.00167	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000256	0.00166	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000252	0.00164	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.00025	0.00162	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000234	0.00152	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000233	0.00151	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000229	0.00149	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000228	0.00148	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000224	0.00145	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000219	0.00142	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000208	0.00135	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000204	0.00132	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000171	0.00111	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000168	0.00109	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000163	0.00106	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.00016	0.00104	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000156	0.00101	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000153	0.00099	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000138	0.000897	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000135	0.000878	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.000132	0.000853	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.000129	0.000835	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000125	0.000811	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000122	0.000794	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000112	0.000729	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.00011	0.000713	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.000103	0.000669	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	0.000101	0.000656	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.000101	0.000655	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.89e-05	0.000642	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.49e-05	0.000551	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.31e-05	0.000539	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.77e-05	0.000504	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.6e-05	0.000493	CbGpPWpGaD
